Many adolescents and young women gain weight in the years after breast reduction surgery – particularly those who were at a healthy body mass index (BMI) before surgery, reports a paper in the February issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Tag: Weight Loss
U. of I. team develops weight loss app that tracks fiber, protein content in meals
A research team at the University of Illinois Urbana-Champaign has developed a weight management program that helps individuals plan meals with the assistance of a web application and support from a registered dietitian. In a new study, they discuss the app’s features, development, and implementation.
What’s Next for Weight Loss in 2025? Some Say It’s Time to Say Goodbye to the BMI, Among Other Things…
This National Healthy Weight Week, there’s a growing call to overhaul the way obesity is currently diagnosed.
Breakthrough obesity treatment: a micro cure for a big problem
University of South Australia researchers have created a new, food-grade, natural solution for obesity, that not only cuts the kilos and improves metabolic health but does so without the nasty side effects.
Is Weight Loss Surgery right for me?
As year-end insurance deductibles are met and plans are made for a healthy start to the new year, many people choose to have elective health procedures such as bariatric surgery around this time. If considering this type of weight loss surgery, what should you keep in mind? A Hackensack Meridian Health expert shares some tips.
Weight loss interventions associated with improvements in several symptoms of PCOS
A systematic review of randomized controlled trials (RCTs) found that weight-loss interventions were associated with improvements in some polycystic ovary syndrome (PCOS) symptoms, including improvement in menstrual frequency, and could be considered a routine treatment option for patients with PCOS.
Can small bursts of activity throughout the day decrease chronic pain?
Setting out to prove that movement indeed is medicine for older adults with chronic knee and hip pain, Wake Forest University researchers have received a $5.7 grant from the National Institutes of Health (NIH) to conduct a five-year study.
Bariatric Surgery Is More Cost Effective Than Newer Weight Loss Drugs Alone
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2024 in San Francisco, California. Further, a second study presented at the meeting found that this increasingly popular class of weight loss drugs, called glucagon-like peptide-1 receptor agonists, or GLP-1 RA, appears safe and may be a novel approach to treating obesity when used before bariatric surgery.
Ovarian Cancer: Silent Killer
Ovarian cancer is often called the “silent killer”. Most of the time it has no symptoms in its early stages. By the time symptoms appear, the cancer may have already spread. This is why regular screenings are so important. Eugene…
Research assesses impact of weight loss and blood sugar control in Type 2 Diabetes
A Cleveland Clinic research team has published the first study assessing the independent real-world impacts of weight loss and blood sugar control on clinical outcomes in people with type 2 diabetes treated with antidiabetic medications, and specifically with GLP-1RAs (the…
Understanding Cancer Patients with Malnutrition and Metabolic Dysfunction
Cancer patients frequently experience metabolic dysfunction leading to severe weight loss correlating with a poor prognosis. Causes for this dysfunction include malnutrition and cachexia, a systemic inflammation affecting brain mechanisms regulating satiety and hunger.
First Patient Dosed in Phase 2 Clinical Study of Palatin’s Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that patient dosing has started for the clinical study entitled: BMT-801: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Clinical Study Investigating the Safety, Tolerability, and Effectiveness of the Co-Administration of Bremelanotide with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity (ClinicalTrials.gov Identifier: NCT06565611).
Combining Two Diabetes Drugs Helps Promote Weight Loss and Blood Sugar Control
New research finds a combination of drugs improves weight loss, glucose control and insulin resistance better than either drug alone. Using two diabetes medications together, such as a semaglutide like Ozempic or Rybelsus, with a second, newer class of drug, may offer a noninvasive solution to help people with Type 2 diabetes lose weight and manage their condition without the need for bariatric surgery.
Swipe up! Health apps deliver real results en masse
They’re the dinky digital tools you can download in a few seconds, but despite their literal size, health and fitness apps pack a real punch when it comes to getting results, say researchers at the University of South Australia.
Navigating a weight loss journey
One patient details her success story losing weight through this individualized approach
Seeking Ozempic Alternatives? Prioritize Safety with These Expert Tips
Ozempic is a medication used to treat type two diabetes, often used for weight loss purposes. Its high cost and need for a prescription has led people on the internet to look for cheaper alternatives. There are several such DIY…
What fat cats on a diet may tell us about obesity in humans
Pet cats may be excellent animal models for the study of obesity origins and treatment in humans, a new study of feline gut microbes suggests – and both species would likely get healthier in the research process, scientists say.
Monell Center Discovery Could Help Reduce Adverse Side Effects of Popular Next-generation Obesity Medications
By teasing apart the therapeutic benefits from the adverse effects of new-generation obesity medications, researchers from the Monell Chemical Senses Center found a population of neurons in the brain that controls food intake without causing nausea in an animal model.
Compound from Olives Shows Promise for Treating Obesity and Diabetes
Findings from a new mouse study suggest that elenolic acid, a natural compound found in olives, can lower blood sugar levels and promote weight loss. The research could pave the way to the development of safe and inexpensive natural products for managing obesity and type 2 diabetes in people.
Pilot Study Provides ‘Blueprint’ for Evaluating Diet’s Effect on Brain Health
Researchers from Johns Hopkins Medicine and the National Institutes of Health’s National Institute on Aging say their study of 40 older adults with obesity and insulin resistance who were randomly assigned to either an intermittent fasting diet or a standard healthy diet approved by the U.S. Department of Agriculture (USDA) offers important clues about the potential benefits of both eating plans on brain health.
Cleveland Clinic Study Shows Weight Loss Surgery Cuts Risk of Heart Complications and Death in Patients with Obstructive Sleep Apnea and Obesity
A Cleveland Clinic study shows that bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnea is associated with a significantly lower risk of death and major adverse cardiovascular events, compared with patients who did not have the surgery. This study was published in the Journal of the American College of Cardiology.
Ali Aminian, M.D., director of Cleveland Clinic’s Bariatric & Metabolic Institute and primary investigator of the MOSAIC study, said, “The research shows that weight loss achieved with bariatric surgery is significantly associated with a 42% lower risk of major adverse cardiovascular events and 37% lower risk of death in patients with obesity and moderate to severe obstructive sleep apnea.”
Intake Reduction and Pre-surgery Body Weight Explain Efficacy of Weight Loss Surgery
A new study finds that pre-surgery weight plays a role in how much weight loss occurs after gastric bypass. The study is published ahead of print in the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology and has been chosen as an APSselect article for June.
Weight loss: Go nuts or go home
New research from the University of South Australia shows that including nuts in calorie-controlled weight loss diets does not hinder weight loss, and instead may have the opposite effect.
Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns
Studies from multiple UChicago experts show that while GLP-1RA drugs are extremely effective for weight loss and Type 2 diabetes treatment, there’s no one-size-fits-all solution and physicians and patients have to consider issues like cost and side effects.
Type of weight loss surgery women undergo before pregnancy may influence children’s weight gain
The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Retrospective Study Based on Electronic Health Records Finds Popular Diabetes and Weight-Loss Drugs Associated with Reduction in Incidence and Recurrence of Alcohol-Use Disorder by at Least Half
A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.
Wake Forest University School of Medicine Awarded $1.5 Million From NIH to Use Advanced Imaging to Assess Bone Loss After Bariatric Surgery
Researchers at Wake Forest University of School of Medicine have received a five-year, $1.5 million grant to study bone microarchitecture in patients following bariatric surgery.
Young people are increasingly using Wegovy and Ozempic
Public interest in weight loss drugs like Wegovy and Ozempic is surging, but national data on dispensing patterns in the United States are surprisingly scarce.
RCT finds calories may be more important than meal timing when it comes to weight loss
A randomized controlled trial comprised of adults with obesity and prediabetes found that both time-restricted eating and a usual eating pattern resulted in weight loss when calories were held constant in both groups.
University Hospital and Rutgers New Jersey Medical School Launch Comprehensive Weight Management Center
University Hospital and Rutgers New Jersey Medical School (NJMS) have established a Weight Management Center designed to address obesity and its complications by providing comprehensive support to patients struggling with weight management through a multidisciplinary approach.
Intermittent Fasting May Help Preserve Intestinal Health as We Age
A study in mice found that intermittent fasting brought benefits beyond weight loss, suggesting it could help the body better process glucose and reduce age-related declines in intestinal function. Researchers will present their work this week at the American Physiology Summit.
WEGOVY APPROVED FOR HEART RISK: U-Mich cardiology, obesity medicine experts available for interview
On March 8, the U.S. Food and Drug Administration approved a new indication for the use of semaglutide (brand Wegovy) to “reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or…
Should heart patients consider taking weight loss medications?
Over the last year, prescriptions for medications that can accelerate weight loss in people with diabetes, or without it, have skyrocketed. But how can these weight loss medications affect the heart? A preventive cardiologist shares how this shifting landscape might affect cardiovascular care and how he advises his patients.
New weight loss medication may help lower blood pressure in adults with obesity
DALLAS, Feb. 5, 2024 —The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took the medication for about eight months, according to new research published today in Hypertension, an American Heart Association journal.
Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins
A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study.
Study Urges People to Think Twice Before Going on a Diet
A new qualitative study highlights the negative interpersonal and psychological consequences associated with “yo-yo dieting,” also known as weight cycling.
Patients more likely to lose weight if physicians offer advice using optimistic tone
An analysis of patient encounters at 38 primary care clinics found that patients were more likely to participate in a recommended weight loss program and lose weight successfully if physicians presented treatments for obesity as good news and as an “opportunity” rather than emphasizing the negative consequences of obesity or using neutral language. The findings are published in Annals of Internal Medicine.
Intermittent fasting is safe, effective for those with Type 2 diabetes
More weight lost among people who fasted, compared to calorie restriction
After body contouring, bariatric surgery patients regain more weight than non-bariatric patients
Patients with previous bariatric surgery who undergo body contouring (BC) regain more weight at long-term follow-up, compared to BC patients who did not have bariatric surgery, reports a study in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
A UCLA-led team may have found the key to stimulating human brown adipose tissue into combating obesity
A UCLA-led team of researchers has found nerve pathways that supply brown adipose tissue (BAT), a type of tissue that releases chemical energy from fat metabolism as heat – a finding that could pave the way toward using it to treat obesity and related metabolic conditions.
UAH Nursing researcher to study cardiometabolic disease among Black women in the Deep South
A researcher at The University of Alabama in Huntsville (UAH) has been awarded a $179,000 subcontract to explore community-based strategies for reducing high-burden chronic disease like obesity, diabetes, heart disease and cancer as part of an overall award totaling $4.2 million.
Exercise-mimicking drug sheds weight, boosts muscle activity in mice
A new drug encourages weight loss and increases endurance by making the body act like it is exercising.
Weight loss? ‘Nuting’ to worry about with almonds
When it comes to weight loss, nuts can get a bad rap – while they’re high in protein, they’re also high in fats, and this often deters those looking to shed a few kilos. But new research from the University of South Australia shows that you can eat almonds and lose weight too.
Obesity experts spotlight safety gap in clinical trials and drug labeling for people with obesity
A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity.
Researchers at UC Irvine issue a warning that GLP-1RA’s may be dangerous for children
A team of clinicians, exercise scientists, pharmaceutical scholars, ethicists, and behavioral experts at the University of California, Irvine, outlined their concerns that the use of glucagon-like peptide-1 receptor agonists (GLP-1RA’s) to treat childhood obesity and type 2 diabetes may have unintended and adverse consequences for children’s health.
![](https://sciencenewsnet.in/wp-content/uploads/2023/07/64c1dacb30e56_peopleeatingshutterstock2131868593.jpg)
Preventing weight gain: Yo-yo no-go zones for Australians
There’s no doubt that Aussies love a good celebration. We’re all in when it comes to the weekend, and most of us can’t go past a Christmas celebration without a little bit of overindulging. But all this comes at a cost, and it’s taking a massive toll on our waistline.
What is the Best Dieting Strategy for People with Type 2 Diabetes?
A new randomized controlled study of people with type 2 diabetes showed that study participants who restricted eating to between noon and 8 p.m. daily lost more weight than those who reduced their overall calorie intake by counting calories.
New Study to Examine Whether Medication and/or Resistance Training Plus Bone-Strengthening Exercises Can Help Older Adults Safely Lose Weight
With $7 million in funding from the National Institutes of Health, researchers from Wake Forest University School of Medicine and Wake Forest University will study whether a combination of resistance training plus bone-strengthening exercises and/or osteoporosis medication use can help older adults safely lose weight without sacrificing bone mass.
McMaster University team discovers hormonal pathway that increases calorie burning during weight loss
The research team studied a hormone called GDF15 that they had previously shown to reduce appetite in response to the type 2 diabetes drug metformin. It was discovered that in mice, GDF15 blocks the slowing of metabolism that occurs during dieting by ramping up calcium futile cycling in muscle.
NUTRITION 2023 Features Leading Nutrition Experts and Groundbreaking Research
Join us at NUTRITION 2023 for an exciting lineup of scientific symposia, educational sessions, hot-topic discussions, and award lectures covering the latest developments in nutrition science. NUTRITION 2023, the annual flagship meeting of the American Society for Nutrition (ASN), will be held July 22-25 at the Sheraton Boston.